4-{4-[4-(2,4-Dichlorophenoxy)-5-methyl-1H-pyrazol-3-yl]-3-hydroxyphenoxy}butanoic Acid

ID: ALA5197870

Chembl Id: CHEMBL5197870

PubChem CID: 168288577

Max Phase: Preclinical

Molecular Formula: C20H18Cl2N2O5

Molecular Weight: 437.28

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1[nH]nc(-c2ccc(OCCCC(=O)O)cc2O)c1Oc1ccc(Cl)cc1Cl

Standard InChI:  InChI=1S/C20H18Cl2N2O5/c1-11-20(29-17-7-4-12(21)9-15(17)22)19(24-23-11)14-6-5-13(10-16(14)25)28-8-2-3-18(26)27/h4-7,9-10,25H,2-3,8H2,1H3,(H,23,24)(H,26,27)

Standard InChI Key:  PRNBQQXTRZIVQI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5197870

    ---

Associated Targets(Human)

LPAR1 Tchem Lysophosphatidic acid receptor Edg-2 (779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LPAR2 Tchem Lysophosphatidic acid receptor Edg-4 (418 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LPAR3 Tchem Lysophosphatidic acid receptor Edg-7 (471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 437.28Molecular Weight (Monoisotopic): 436.0593AlogP: 5.43#Rotatable Bonds: 8
Polar Surface Area: 104.67Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.05CX Basic pKa: 1.88CX LogP: 4.76CX LogD: 1.57
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.41Np Likeness Score: -0.77

References

1. Khiar-Fernández N, Zian D, Vázquez-Villa H, Martínez RF, Escobar-Peña A, Foronda-Sainz R, Ray M, Puigdomenech-Poch M, Cincilla G, Sánchez-Martínez M, Kihara Y, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S..  (2022)  Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice.,  65  (16.0): [PMID:35948083] [10.1021/acs.jmedchem.2c00046]

Source